A cornerstone of cancer diagnostics
Cytogenetics is the study of normal and abnormal chromosomes in relation to disease. Sometimes called chromosome analysis or karyotyping, cytogenetic tests are used to gain diagnostic and prognostic insights regarding solid tumor cancers and hematologic malignancies, which can be the result of chromosome rearrangements or altered chromosome number (ploidy).
Our cytogenetic tests include a traditional G-banding for metaphase analysis with an added proprietary wet lab process that enhances the length of chromosomes, improves test resolution, and makes the detection of chromosomal changes more reliable – all to ensure that you and your patients get world-class quality results.
Highlights of Our Cytogenetics Program
Industry-leading turnaround - Results on blood and bone marrow in 6 days
Standard and special specimens - Including solid tumor
Extensive FISH library - For efficient case follow-up as needed
Automated metaphase identification - For improved efficiency and accuracy
Multi-stepped analysis - Two independent technologists + quality control for each case
Board-certified sign-off - For authoritative confirmation and results
Cytogenetics Testing
Bone marrow chromosome analysis is routinely done for diagnostic classification and/or determining prognosis of newly diagnosed leukemias. Concurrent peripheral blood studies may also be performed, while lymph nodes are preferred for most lymphomas. NeoGenomics has extensive experience with the difficult tissue culture and complex karyotypes that often accompany solid tumor cytogenetics. Highlights at NeoGenomics include:
- karyotypes
- metaphase spreads
- ideograms
- translocations, deletions and extra chromosomes
Quality cytogenetic studies remain a cornerstone of cancer diagnostics. While 2020 marked the 60-year anniversary of the first association of a chromosome abnormality with a specific cancer (the Philadelphia chromosome in CML), cancer cytogenetics have retained their unique value in hematologic and solid tumor cancers by providing whole genome assessments at the single-cell level. {extra text for SEO: Bone marrow chromosome analysis is routinely done for diagnostic classification and/or determining the prognosis of newly diagnosed leukemias. Concurrent peripheral blood studies may also be performed, while lymph nodes are preferred for most lymphomas. NeoGenomics has extensive experience with the difficult tissue culture and complex karyotypes that often accompany solid tumor cytogenetics. Highlights at NeoGenomics include:
- 6-day turnaround time for blood and bone marrow analysis
- Industry-leading in-house FISH probe library for efficient & comprehensive case follow-up in hematologic neoplasms and solid tumors
- Continuous workload optimization through bi-coastal and central laboratories, plus additional analysis only “dry lab” sites
- Fostering industry and employee growth with Florida state-approved technologist training program
NeoGenomics prides itself on our unparalleled customer support team. If you have questions regarding test information, specimen requirements, turnaround times, test add-on, and patient results, please feel free to reach out to a Client Services Advocate at client.services@neogenomics.com.
View our full menu of available cytogenetics tests with printable descriptions and specimen requirements.
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients